Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells
- 15 October 2010
- journal article
- Published by Informa UK Limited in Cancer Biology & Therapy
- Vol. 10 (8), 758-764
- https://doi.org/10.4161/cbt.10.8.12878
Abstract
The neurofibroma, a common feature of neurofibromatosis type 1 (NF1), is a benign peripheral nerve sheath tumor that contains predominantly Schwann cells (SC). There are reports that neurofibroma growth may be affected by hormonal changes, particularly in puberty and pregnancy, suggesting an influence by steroid hormones. This study examined the effects of estrogen and progesterone on proliferation and apoptosis in a panel of NF1 tumor xenografts. SC-enriched cultures derived from three human NF1 tumor types (dermal neurofibroma, plexiform neurofibroma, and malignant peripheral nerve sheath tumor (MPNST)) were xenografted in sciatic nerves of ovariectomized scid /Nf1-/+ mice. At the same time, mice were implanted with time-release pellets for systemic delivery of progesterone, estrogen or placebo. Proliferation and apoptosis by the xenografted SC were examined two months after implantation, by Ki67 immunolabeling and TUNEL. Estrogen was found to increase the growth of all three MPNST xenografts. Progesterone was associated with increased growth in two of the three MPNSTs, yet decreased growth of the other. Of the four dermal neurofibroma xenografts tested, estrogen caused a statistically significant growth increase in one, and progesterone did in another. Of the four plexiform neurofibroma SC xenografts, estrogen and progesterone significantly decreased growth in one of the xenografts, but not the other three. No relationship of patient age or gender to steroid response was observed. These findings indicate that human NF1 Schwann cells derived from some tumors show increased proliferation or decreased apoptosis in response to particular steroid hormones in a mouse xenograft model. This suggests that anti-estrogen or anti-progesterone therapies may be worth considering for specific NF1 neurofibromas and MPNSTs.Keywords
This publication has 52 references indexed in Scilit:
- Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast CancerClinical Cancer Research, 2009
- Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival geneEMBO Molecular Medicine, 2009
- Neurofibromin physically interacts with the N‐terminal domain of focal adhesion kinaseMolecular Carcinogenesis, 2009
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 2006
- Time course of response to estradiol replacement in ovariectomized mice: Brain apolipoprotein E and synaptophysin transiently increase and glial fibrillary acidic protein is suppressedExperimental Neurology, 2006
- Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cellsCancer Genetics and Cytogenetics, 2005
- Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumoursEuropean Journal Of Cancer, 2004
- Combined inhibition of estrogen‐dependent human breast carcinoma by soy and tea bioactive components in miceInternational Journal of Cancer, 2003
- Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1Journal of Clinical Pathology, 2003
- Stimulation of rat Schwann cell proliferation by estradiol: synergism between the estrogen and cAMPDevelopmental Brain Research, 1993